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Abstract
Background: Various Burden of Disease (BoD) studies do not account for multimorbidity in their BoD estimates.
Ignoring multimorbidity can lead to inaccuracies in BoD estimations, particularly in ageing populations that include
large proportions of persons with two or more health conditions. The objective of this study is to improve BoD
estimates for the Netherlands by accounting for multimorbidity. For this purpose, we analyzed different methods
for 1) estimating the prevalence of multimorbidity and 2) deriving Disability Weights (DWs) for multimorbidity by
using existing data on single health conditions.
Methods: We included 25 health conditions from the Dutch Burden of Disease study that have a high rate of
prevalence and that make a large contribution to the total number of Years Lived with a Disability (YLD). First, we
analyzed four methods for estimating the prevalence of multimorbid conditions (i.e. independent, independent
age- and sex-specific, dependent, and dependent sex- and age-specific). Secondly, we analyzed three methods for
calculating the Combined Disability Weights (CDWs) associated with multimorbid conditions (i.e. additive, multiplicative
and maximum limit). A combination of these two approaches was used to recalculate the number of YLDs, which is a
component of the Disability-Adjusted Life Years (DALY).
Results: This study shows that the YLD estimates for 25 health conditions calculated using the multiplicative method
for Combined Disability Weights are 5 % lower, and 14 % lower when using the maximum limit method, than when
calculated using the additive method. Adjusting for sex- and age-specific dependent co-occurrence of health conditions
reduces the number of YLDs by 10 % for the multiplicative method and by 26 % for the maximum limit method. The
adjustment is higher for health conditions with a higher prevalence in old age, like heart failure (up to 43 %) and
coronary heart diseases (up to 33 %). Health conditions with a high prevalence in middle age, such as anxiety
disorders, have a moderate adjustment (up to 13 %).
Conclusions: We conclude that BoD calculations that do not account for multimorbidity can result in an overestimation
of the actual BoD. This may affect public health policy strategies that focus on single health conditions if the underlying
cost-effectiveness analysis overestimates the intended effects. The methodology used in this study could be further
refined to provide greater insight into co-occurrence and the possible consequences of multimorbid conditions in terms
of disability for particular combinations of health conditions.
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Background
The Disability-Adjusted Life Year (DALY) is a widely used
measure to quantify the burden of disease (BoD) in a popu-
lation and to prioritize public health policy [1]. The DALY
factors in premature mortality as expressed in Years of Life
Lost (YLLs), and loss of quality of life due to suboptimal
health status as expressed in Years Lived with a Disability
(YLDs). The latter measure indicates the morbidity level,
combining the occurrence of health conditions and
their severity as represented by the Disability Weight
(DW) [2, 3]. YLD calculations are based on a preva-
lence perspective, which is considered an adequate
measurement of the level of disability experienced in a
particular population at a particular moment in time
[4]. The incidence perspective, on the other hand, com-
bines the incidence of a particular event and its duration,
and provides a measure of the loss of health connected
with events in a given time period [Schroeder 2012].
Ignoring multimorbidity (i.e. co-occurrence of multiple
health conditions within one person [5]), as has been done
in various BoD studies so far, might result in overesti-
mation of the number of YLDs and therefore overesti-
mation of the overall disease burden [6, 7]. Also in Dutch
studies, YLD calculations do not account for multimorbid-
ity; for example, those included in the latest Public Health
Status and Forecasts (PHSF) report [8]. This same publi-
cation, however, did recognize the importance of multi-
morbidity, reporting that in 2011, 1.9 million persons had
two or more health conditions, representing 11 % of the
Dutch population, with a projected increase to 3 million
persons or 17 % by 2030. Multimorbidity occurs more
often at older ages than at younger ages. Correcting for
multimorbidity is therefore relevant to support policy
intervention strategies, especially those aimed at an
ageing population.
Accounting for multimorbidity in BoD studies requires
not only estimates of the prevalence of multimorbid condi-
tions, but also estimates of the severity of (two or more)
health conditions [6]. Existing studies on the prevalence of
multimorbid conditions are limited to combinations of
two health conditions [9]. The Disability Weights associ-
ated with multimorbid conditions can be determined by
means of a direct population sample, but this method is
costly and time-consuming. Alternative approaches have
been developed that derive the Disability Weights associ-
ated with multimorbid conditions from the underlying sin-
gle health conditions. The three most frequently used
methods are the additive, multiplicative and maximum
limit methods [6, 10–13]. To date, there is a lack of studies
providing insight into the possible effects on the disease
burden of combining the approaches for determining the
prevalence of multimorbid conditions and the associated
Disability Weights.
The objective of this study is to apply different methods
for estimating the prevalence of multimorbidity and esti-
mating the Disability Weights associated with multimor-
bid conditions. In addition, we analyzed the effects that
combining these methods would have on the number of
YLDs. This analysis was performed using existing data
concerning the prevalence of 25 selected health conditions
in the Netherlands.
Methods
In this context, multimorbidity is defined as the co-
occurrence of multiple chronic or acute diseases and
medical conditions within one person [5]. To take multi-
morbidity into account, various methods have been
included in the analysis (see Fig. 1). These methods apply
to the prevalence of multimorbidity (Fig. 1, left) as well as
the Combined Disability Weights (CDWs) (Fig. 1, right).
Fig. 1 Various methodologies to account for multimorbidity prevalence and Disability Weights
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We included four methods for estimating the prevalence
of multimorbidity and three methods for determining
Combined Disability Weights, resulting in 12 variants for
calculating the effect of multimorbidity on the BoD. As a
reference for these variants, we used the approach applied
in the PHSF report [7], which actually is one of the
variants.
Data and selection of health conditions
The data used to analyze multimorbidity consist of the
data on the prevalence of health conditions and Disability
Weights as published in the Dutch Public Health Status
and Forecasts report (PHSF, [8]). The health conditions
reported in the PHSF are considered the most relevant
conditions in the Netherlands in terms of mortality, preva-
lence, cost, and impact on individuals and society [14].
Prevalence data for the health conditions have been de-
rived from sources including GP registration databases
and the Netherlands Cancer Registry, and are available by
sex and for 5-year age cohorts, with persons over the
age of 85 as the last age cohort. Disability weights were
assigned to these health conditions based on the find-
ings of the Dutch Disability Weights Study [15]. We
have selected 25 health conditions for analysis, based
on the following criteria: 1) high prevalence, 2) large
contribution to the YLD component of the disease bur-
den, and 3) variation in types (both mental and phys-
ical) (Table 1).
Different approaches to estimating the prevalence of
multimorbidity
Various methods are used to calculate the prevalence of
combinations of health conditions, based on existing data
on the prevalence of single health conditions (Fig. 1):
 In Method A and C, health conditions are
considered independently, as assumed in the GBD
studies for 2010 and 2013 [3, 16]. This means that
the occurrence of one health condition is assumed to
have no effect on the occurrence of another health
condition. In Method A, the calculations are
performed for the entire population (non-age-specific
and non-sex-specific). In Method C, calculations are
stratified by gender and by 5-year age cohort.
 In Method B and D, the occurrence of health
conditions is assumed to be interdependent. This
is taken into account in the calculations by
applying a dependence correction factor. In this
study, dependence is only applied to combinations
of two health conditions, due to a lack of insight
into and data about combinations of more than
two conditions. Combinations of more than two
health conditions are regarded as occurring
independently, as in Method A and C. Method B
is applied to the entire population (non-age-
specific and non-sex-specific). In Method D, the
calculations are stratified by gender and by 5-year
age cohort.
Method A and C represent the most straightforward
approach, and assume that health conditions occur inde-
pendently. Suppose we have n health conditions and the
probability of having health condition i is pi for i in 1… n.
The probability of having both health conditions i
and j is:
pij; indep ¼ pi  pj ð1Þ
The probability of having only two health conditions i
and j, and no other health condition, is:
pij; indep
0 ¼ pi  pj  1−p1ð Þ …  1−pnð Þ
1−pið Þ  1−pj
  ð2Þ
Table 1 Overview of the 25 health conditions included in the
analysis: prevalence, Disability Weight (DW), Years Lived with a
Disability (YLD), and Disability-Adjusted Life Years (DALY), 2011 [34]
Prevalence DW YLD DALY
Arthrosis 7.12 % 0.103 122,423 123,509
Anxiety disorders 5.77 % 0.187 180,220 180,272
Diabetes mellitus 5.00 % 0.198 165,150 194,312
Hearing disorders 4.86 % 0.109 88,344 88,344
Mood disorders 2.31 % 0.425 164,025 164,592
Neck and back pain 3.91 % 0.236 153,930 154,499
Coronary heart disease 3.62 % 0.288 174,090 282,834
Asthma 2.86 % 0.080 38,192 39,244
COPD 2.17 % 0.314 113,600 177,809
Contact eczema 1.94 % 0.070 22,720 22,720
Visual impairments 1.81 % 0.137 41,348 41,375
Cardiac arrhythmias 1.17 % 0.154 30,142 48,305
Stroke 1.11 % 0.609 113,147 191,320
Breast cancer 0.60 % 0.265 26,459 88,019
Heart failure 0.85 % 0.154 21,809 67,660
Intellectual disabilities 0.77 % 0.430 55,599 56,929
Personality disorders 0.60 % 0.273 27,438 27,438
Colon cancer 0.36 % 0.294 17,667 87,177
Prostate cancer 0.40 % 0.231 15,271 39,403
Dementia 0.48 % 0.678 54,744 112,130
Valve problems 0.46 % 0.118 9091 28,346
Skin cancer 0.24 % 0.070 2768 19,446
Lung cancer 0.12 % 0.285 5845 169,120
Parkinson’s disease 0.19 % 0.497 15,401 25,657
Non-Hodgkin’s lymphoma 0.13 % 0.233 4910 20,749
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For 25 health conditions, there are more than 33 mil-
lion possible combinations. Calculating the prevalence of
these combinations requires a great deal of computing
capacity. However, when health conditions are assumed
to occur independently, the probability of having more
than five health conditions is very small (no more than
1.5 in a million). We therefore limited our analyses to
combinations of no more than five health conditions out
of a total of 25 health conditions, which resulted in
68,405 unique combinations.
This approach disregards two important issues. Firstly,
different health conditions may have shared risk factors
(e.g. smoking not only increases the risk of a stroke but
also of developing COPD). Secondly, some health condi-
tions may increase the risk of getting another health condi-
tion, e.g. diabetes mellitus and cardiovascular diseases. As
a result, some combinations of health conditions occur
more frequently than might be expected if independence is
assumed. Odds ratios (i.e. the ratio of the odds of the
observed prevalence of two health conditions compared to
the prevalence when independence is assumed) can be
used to calculate the prevalence corrected for dependence.
Van Oostrom et al. [17] published the odds ratios for nine
health conditions (i.e. the ratio between observed and in-
dependent prevalence) in an older population. Only eight
of these health conditions appear in our list of 25 health
conditions. Since odds ratios for combinations of the 25
health conditions are not available, we used the median of
the odds ratios reported by Van Oostrom et al. [17] (i.e. an
odds ratio of 1.3). These odds ratios are only applied to
combinations of two health conditions, since no data are
currently available on odds ratios for combinations of
more than two health conditions. This adjustment for
interdependence between the prevalence of two health
conditions is included in Method B and D.
The ratio ORij between the odds of the real prevalence
pij,dep assuming interdependence between two health con-
ditions i and j, and the odds of the prevalence assuming
independence pij, indep between those two conditions may




  = pij; indep
1−pij; indep
  ð3Þ
This formula can be rewritten as:









When odds ratios are used, pij, dep is always between 0
and 1. When the odds ratios are known, pij, dep can be
calculated for each combination of two health conditions.
In all methods, these probabilities replace the probabil-
ities of the occurrence of combinations of two health
conditions based on independence. In order to keep the
total probability of health condition i and j the same,
the probability that people only have health condition
i (pi ') or j (pj ') is adjusted as follows:
p
0






j;dep ¼ pj0− pij;dep− pij;indep
 
ð6Þ
The probability p0 of having none of the n health con-
ditions is adjusted as follows:





pij; dep− pij; indep
 
ð7Þ
Calculating the prevalence by gender and age may result
in a lower prevalence for some combinations of health
conditions compared to calculations for the population as
a whole. For example, asthma is more prevalent among
young people, and will therefore not occur as often in
combination with old-age-related health conditions such
as dementia. On the other hand, dementia will occur more
often in combination with other chronic health conditions
like arthrosis because of the age-related nature of these
conditions.
Different approaches to Combined Disability Weights
(CDWs)
To adjust the Disability Weights for multimorbidity,
we applied three approaches: the additive approach
(Method 1), the multiplicative approach (Method 2) –
as assumed in the GBD studies for both 2010 and 2013
[3, 16] – and the maximum limit approach (Method 3).
These three methods exclude the possibility that a com-
bined multimorbidity effect in terms of disability can be
higher than the sum of the underlying disabilities. At the
individual level, there may be combinations that could
result in so-called over-additivity. We have assumed that
over-additivity is less relevant at population level, and have
therefore not included it in our analysis.
Method 1 (Fig. 1) represents an additive model in which
the resulting impact of combined health conditions is de-
fined as the sum of the impacts of the individual health
conditions. It is assumed that the impact of each health
condition is the same, regardless of the presence of other
conditions. The Combined Disability Weight of health
conditions i and j is therefore calculated as follows:
DWij ¼ DWi þ DWj ð8Þ
where DWi is the Disability Weight of health condition i,
and DWj is the Disability Weight of health condition j.
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Method 2 represents a multiplicative model in which
each health condition proportionally contributes to the
Combined Disability Weight. The Combined Disability
Weight of health conditions i and j is therefore calculated
as follows:
DWij ¼ 1− 1−DWið Þ  1−DWj
  ð9Þ
In Method 3, the maximum limit approach ignores
co-existing health conditions and assumes that the
most serious condition “trumps” the others. The Com-
bined Disability Weight of health conditions i and j is
therefore calculated as follows:
DWij ¼ max DWi; DWj
  ð10Þ
Years Lived with a Disability (YLD)
The overall objective is to estimate the health loss that is
associated with a specific health condition, as well as the
overall health loss from all health conditions occurring
in a population. The number of Years Lived with a Dis-
ability (YLD) for health condition i is considered from a
prevalence perspective [4], and may be calculated as
follows:
YLDi ¼ pi  DWi ð11Þ




pi  DWi ð12Þ
where piis the prevalence of health condition i, DWi
is the corresponding Disability Weight, and n is the
total number of health conditions occurring in a
population. This calculation implicitly assumes that
when a person has more than one health condition, the
disabilities associated with these health conditions may be
added up (Eq. 12). This assumption most likely results in
an overestimation of the total number of YLDs in the
population.
In order to determine how much of the disability can
be attributed to a specific health condition, the fraction
of the Disability Weight (DWF) that is attributable to a
specific health condition is calculated [18]. If a person
has k different health conditions with corresponding
Disability Weights DW1…DWk, the DWF attributable
to health condition i may be calculated as follows:
DWFi ¼ DWiDW 1 þ…þ DWk ð13Þ
The attributable Disability Weight DWAi caused by
health condition i in this person may be calculated as
follows:
DWAi ¼ DWFi  DW 1…k ð14Þ
where DW1… k is the Combined Disability Weight of
health conditions 1… k
If these formulas are applied to the three different
methods for calculating Combined Disability Weights,
the results are as follows:
Method 1 : DWAi ¼ DWFi  DW 1…k ¼ DWiDW 1 þ…þ DWk
 DW 1 þ…þ DWkð Þ ¼ DWi
ð15Þ
Method 2 : DWAi ¼ DWFi  DW 1…k ¼ DWiDW 1 þ…þ DWk
 1− 1−DW 1ð Þ …  1−DWkð Þð Þ
ð16Þ
Method 3 : DWAi ¼ DWFi  DW 1…k ¼ DWiDW 1 þ…þ DWk
max DW 1;…; DWkð Þ
ð17Þ
Suppose t people in a population have health condi-
tion i. The YLDs attributable to health condition i in the





where DWAip is the attributable Disability Weight caused
by health condition i in a person p.
The analyses were performed using R version 3.1.0.
The R-scripts are available upon request.
Results
Prevalence of multimorbidity
Figure 2 shows that, when independence is assumed be-
tween health conditions in the overall study population
(i.e. applying Method A), almost 60 % of the population
does not have any health condition, about 30 % has one
of the selected health conditions, 8 % has two health
conditions, and 3 % has three or more health conditions.
When independence between health conditions is as-
sumed in age- and sex-specific analyses (i.e. Method C),
the results show that 35 % of the population has at least
one health condition (Fig. 2). When Method B is applied
and interdependence between different health conditions is
assumed, the prevalence is slightly lower for single health
conditions and slightly higher for double health conditions
compared to the results produced by Method A.
Figure 3 shows the relative (left) and absolute (right)
age- and sex-specific prevalence of the average number of
health conditions in a person, determined in accordance
with Method C. A clustering of health conditions
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occurs at higher ages (75 years and over). The propor-
tion of the population without any health conditions is
10 % in the 75+ age cohort, and around 60 % has two
or more health conditions. This age-specific pattern is
similar for men and women in relative terms, although
women outnumber men at higher ages in absolute
terms, resulting in a higher contribution by women
to the health condition burden (results included in
Appendix).
Looking at specific health conditions, there is a distinct
difference between total-population methods (Methods A
and C) and sex- and age-specific methods (Methods B
and D). Figure 4 shows the differences between Method A
and Method C. Although the overall prevalence of health
conditions displays a relatively wide range of variation
(Table 1), the probability of occurrence of a single health
condition either by itself or in combination with one or
more of the other 24 health conditions shows little vari-
ation in Method A (Fig. 4, left). This can be explained by
looking at the probability of not having any other health
condition, which has a strong commonality for different
health conditions. In Method C and D, the underlying
age-specific variation in prevalence results in greater over-
all variation. Applying Method C (Fig. 4, right) shows that
the vast majority of dementia cases (almost 90 %) occur in
combination with another health condition, due to a clus-
tering of chronic health conditions at higher ages. In con-
trast, anxiety disorders may be regarded as a health
condition typical of middle age and co-occur with another
health condition in only 30 % of cases, assuming inde-
pendent occurrence.
Three different methods for calculating Combined
Disability Weights
The Disability Weights for the 25 selected health condi-
tions range from 0.070 to 0.678 (Table 1). Figure 5 shows
the distribution of Disability Weights when three different
calculation methods are applied, for all possible combina-
tions of health conditions. These combinations concern
the simultaneous occurrence of one to five health condi-
tions. When looking at a combination of five health condi-
tions, the Combined Disability Weights range from 0.432
to 2.639 when the additive method is applied. By defin-
ition, the Disability Weight should not exceed 1 (which
corresponds with death), although this may occur when
the additive method is applied. When the multiplicative





0 1 2 3 4 5 > 5






Method A: Independence (total population)
Method B: Dependency correction (total population)
Method C: Independence (sex−age specific population)
Method D: Dependency correction (sex−age specific population)
Fig. 2 Prevalence of average number of health conditions in a person
(determined using the four methods for calculating the prevalence of






















































































































































Fig. 3 Relative (left) and absolute (right) prevalence of average number of health conditions in a person by age, determined using Method C
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have a smaller range (0.364 - 0.979). Application of the
maximum limit method results in even lower Disability
Weights (0.109 - 0.678). In general, the maximum limit
method (Method 3) results in the largest downward ad-
justment of the Combined Disability Weight (CDW) com-
pared to the additive method. When the multiplicative
method is applied, the resulting CDWs are higher than
when Method 3 is applied, but lower than when Method 1
is applied (see Fig. 5).
Impact of different methods for calculating prevalence
and Disability Weight on YLD estimates
Combining the methods for calculating the prevalence of
multimorbidity and the methods for calculating the
Disability Weights of multimorbid conditions results in
twelve disease burden outcomes for the selected 25 condi-
tions, expressed in YLDs (Fig. 6). The YLDs calculated
using Method A (no sex or age specificity) in combination
with Method 1 (additive method) actually correspond to
not taking multimorbidity into account, and amount to a
total of 1.72 million years lived with disability for the 25
selected health conditions. This combination serves as a
reference for the other eleven combinations. Calculating
YLDs based on the assumption of independent prevalence
(Method A) in combination with the multiplicative
approach (Method 2) for combining Disability Weights –
which corresponds to the perspective of the GBD studies
[3, 16] – yields 1.64 million years lived with a disability.
This corresponds to a downward adjustment of 4.6 %
compared to not taking multimorbidity into account.
Fig. 4 Total-population (Method A, left) and sex- and age-specific (Method C, right) calculated prevalence of average number of health conditions
in a person, by health condition
Fig. 5 Box plot of the distribution of Disability Weights for the three methods for calculating Combined Disability Weights
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Calculating the sex- and age-specific prevalence assuming
interdependence (Method D) in combination with the
maximum limit method (Method 3) results in the largest
downward YLD adjustment, by 26 % to a level of 1.28 mil-
lion years lived with a disability. The YLD adjustment
when the multiplicative method (Method 2) is used,
amounts to 10 % for sex- and age-specific prevalence
(Method D).
Looking at specific health conditions, anxiety disorders
are associated with a moderate adjustment of the related-
disease burden (up to 13 %, Fig. 7), because of a relative
high prevalence in middle age (25–45 years). The health
conditions that are associated with a high adjustment,
such as coronary heart disease (up to 33 %) and heart
failure (up to 43 %), all show a strong increase in preva-
lence with age.
The Appendix includes a table that provides the re-
sults for all twelve methods, for all 25 selected health
conditions.
Discussion
A key focus area in multimorbidity research is the de-
velopment of tools to explore multimorbidity and its
impact on, for example, burden of disease, disability
and quality of life [19]. Various Burden of Disease
(BoD) studies do not account for multimorbidity in
their BoD estimates. In this study, we applied four
different methods to estimate the prevalence of multi-
morbidity, and three different methods to calculate
the Disability Weights associated with multimorbid
conditions. This resulted in twelve different calcula-
tions of the number of Years Lived with a Disability
(YLDs), in order to analyze the impact of multimor-
bidity on BoD estimates in the Netherlands. We found
that multimorbidity adjustments can have a substan-
tial impact on YLD estimates for the 25 health condi-
tions included in our analysis. When a multiplicative
method is applied to determine Combined Disability
Weights, the YLDs are 5 % lower than when the addi-
tive method is used, and 14 % lower than when the max-
imum limit method is used. Adjusting for the sex- and
age-specific dependent co-occurrence of health conditions
Fig. 6 YLD estimates determined using the methods for estimating
prevalence and Disability Weights
Fig. 7 YLD estimates for anxiety disorders and coronary heart disease, determined using the different methods
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reduces YLD estimates by 10 % when the multiplicative
method is used, and by 26 % when the maximum limit
method is used.
Considering the four different methods for estimat-
ing the prevalence of multimorbidity, we found the
highest level of clustering of health conditions in the
sex- and age-specific calculation (Methods C and D),
i.e. a relatively high occurrence of multimorbidity.
Some studies have estimated the overall prevalence of
multimorbidity in both the general population and in
primary care settings, leading to marked variations
among studies with respect to both methodology and
findings [20–22]. Based on an analysis of registration
data for 29 health conditions, Van Oostrom et al. [17]
found that 17 % of primary care patients in the
Netherlands are disease-free and 59 % have two or
more health conditions [17].
When looking at specific clusters of health condi-
tions, our approach to estimating the prevalence of
multimorbidity resulted in a stronger correlation be-
tween health conditions that progress with age, such as
dementia and cardiovascular diseases. We did not ad-
just for possible higher interdependence between spe-
cific combinations of health conditions. In a systematic
review of data on older adults with multiple chronic
diseases, it was found that the combinations with the
highest prevalence rates included hypertension, coron-
ary artery disease and diabetes mellitus [20]. A German
study found three multimorbidity patterns through
both factor analysis and network analysis: 1) cardiovas-
cular/metabolic disorders, 2) anxiety/depression/soma-
toform disorders and pain, and 3) neuropsychiatric
disorders [23, 24]. In general, there is limited insight
into the prevalence of specific disease clusters, espe-
cially for combinations of more than two health condi-
tions. Due to this lack of data, the value of the
dependence correction factor used in our analyses (1.3)
is based on the median reported in the literature. This
factor may be lower or higher for certain combinations
(e.g. cardiovascular diseases show odds ratios of 5.9
[9]). Sensitivity analyses show a negative linear correl-
ation between the dependence correction factor and
the YLD estimates (see Appendix). In our analysis,
dependence between health conditions is limited to
combinations of two health conditions, since adequate
information about the occurrence of more than two
health conditions is lacking. This implies that the
prevalence of multimorbidity adjusted for dependence
between health conditions is underestimated, and that a
larger downward YLD adjustment should therefore be
applied.
In addition to methods for estimating the prevalence of
multimorbidity, we explored three different methods
for determining the Combined Disability Weight of
multimorbidity. The simultaneous occurrence of multiple
health conditions may have less impact on a person’s
health than might be expected based on the sum of the
impacts of the individual health conditions. However,
there is no golden standard for estimating Combined
Disability Weights. There are specific findings about
applying these methods, and an alternative non-
parametric method has even been developed. This so-
called adjusted decrement estimator method is a variation
on the maximum limit method ([11, 13]). However, many
studies [13, 25, 26] use utility measures such as EQ-5D
scores or Health Utilities Index Mark 3 (HUI3) instead of
Disability Weights, resulting in profound differences.
Haagsma et al. [12] compared three comorbidity ap-
proaches in patients with temporary injury consequences
as well as comorbid chronic conditions with non-trivial
health impacts. They found that the Disability Weight
of injury patients increases proportionally to the
number of comorbid health conditions. The Disability
Weights in the study by Haagsma et al. were based on
EQ-5D scores [12], while in our study the Disability
Weights were derived from the Dutch Disability
Weights Study [15]. The most effective method in each
case depends to a large extent on the available data,
and most studies conclude that further research is
required to validate the results found [11, 25, 27–30].
This study focuses on accounting for multimorbidity to
produce more accurate YLD estimates. However, one
could argue that a similar approach may be applied to
YLL estimates. Accounting for “multiple causes of
death” – i.e. accounting not only for primary causes of
death but also for secondary or even tertiary causes –
could alter the allocation of YLLs to specific causes of
death [31, 32]. Research on this is still in its infancy,
however.
Conclusions
Burden of Disease (BoD) calculations that do not ac-
count for multimorbidity can result in an overesti-
mation of the real BoD. This may affect public health
policy strategies that focus on single health conditions
[33]. For instance, cost-effectiveness analyses might
overestimate intended effects when focusing on one
particular health condition without accounting for mul-
timorbidity. Furthermore, applying the independent
prevalence method (Method A) in combination with
the multiplicative approach (Method 2) for combining
Disability Weights is a preferred approach to account
for multimorbidity. This approach to YLD estimates is
relatively simple, and may serve as the preferred ap-
proach until more insight has been gained into the
dependent co-occurrence of health conditions and the
consequences of multimorbid conditions in terms of
Disability Weight.
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175,000 167,000 150,000 175,000 165,000 144,000 174,000 155,000 124,000 174,000 153,000 118,000
Diabetes
mellitus
167,000 160,000 142,000 167,000 159,000 136,000 166,000 152,000 122,000 166,000 151,000 116,000
Mood
disorders
164,000 155,000 143,000 164,000 153,000 139,000 164,000 156,000 146,000 164,000 154,000 143,000
Neck and
back pain
155,000 148,000 131,000 155,000 146,000 126,000 154,000 145,000 125,000 154,000 143,000 120,000
Arthrosis 124,000 120,000 107,000 124,000 119,000 104,000 123,000 114,000 92,000 123,000 113,000 88,000
COPD 115,000 109,000 98,000 115,000 108,000 95,000 114,000 102,000 83,000 114,000 101,000 79,000
Stroke 115,000 107,000 103,000 115,000 106,000 100,000 113,000 97,000 88,000 113,000 95,000 85,000
Hearing
disorders
89,000 86,000 76,000 89,000 86,000 74,000 88,000 82,000 65,000 88,000 81,000 62,000
Intellectual
disabilities
56,000 52,000 48,000 56,000 52,000 47,000 56,000 53,000 50,000 56,000 53,000 49,000
Dementia 54,000 51,000 49,000 54,000 50,000 48,000 53,000 42,000 38,000 53,000 42,000 37,000
Breast
cancer
47,000 45,000 40,000 47,000 45,000 38,000 47,000 42,000 34,000 47,000 42,000 32,000
Visual
impairments
42,000 40,000 35,000 42,000 40,000 34,000 41,000 37,000 28,000 41,000 37,000 26,000
Asthma 38,000 37,000 33,000 38,000 37,000 32,000 38,000 37,000 34,000 38,000 37,000 33,000
Cardiac
arrhythmias
30,000 29,000 25,000 30,000 29,000 24,000 30,000 27,000 20,000 30,000 27,000 19,000
Colon
cancer
30,000 28,000 25,000 30,000 28,000 24,000 29,000 26,000 19,000 29,000 25,000 18,000
Personality
disorders
27,000 26,000 23,000 27,000 26,000 22,000 27,000 26,000 24,000 27,000 26,000 23,000
Contact
Eczema
23,000 22,000 20,000 23,000 22,000 19,000 23,000 22,000 19,000 23,000 22,000 19,000















Table 2 Results in YLDs for all twelve methods, for all 25 health conditions (Continued)
Prostate
cancer
19,000 18,000 16,000 19,000 18,000 15,000 19,000 16,000 12,000 19,000 16,000 11,000
Parkinsons
disease
15,000 14,000 13,000 15,000 13,000 12,000 14,000 12,000 10,000 14,000 12,000 10,000
Lung cancer 12,000 12,000 10,000 12,000 12,000 10,000 12,000 11,000 8,000 12,000 11,000 8,000
Valve
problems




5,000 5,000 4,000 5,000 5,000 4,000 5,000 4,000 3,000 5,000 4,000 3,000



















Fig. 8 Top 10 of health conditions with the highest prevalence rates
Fig. 9 Top 10 of health conditions with the highest YLD
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Fig. 10 Number of people with more than one health condition by sex and age (Method C)
Fig. 11 Prevalence of average number of health conditions in a person for different dependency correction factors
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Fig. 12 Prevalence of average number of health conditions in a person for different dependency correction factors
Fig. 13 Years Lived with Disability (YLDs) by age (Method C)
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